Health Condition 1: I21- Acute myocardial infarction
Conditions
Interventions
Intervention1: Nil: Nil
Intervention2: NIL: NIL
Intervention3: NIL: NIL
Control Intervention1: NIL: NIL
Sponsors
Kasturba Medical College Manipal
Eligibility
Inclusion criteria
Inclusion criteria: Adults more than 18 years Hospitalisation with confirmed AMI, STEMI, or NSTEMI Willingness to provide the written informed consent.
Exclusion criteria
Exclusion criteria: Type 2 MI demand ischemia Pregnant women Severe cytopenias with absolute neutrophil count less than 120 x 10^9 per L or platelet count less than 120 x 10^9 per L Patients currently enrolled in clinical studies involving investigational drugs or any other clinical trials Malignancy or expected life expectancy of less than 1 year Refusal or inability to provide informed consent Severe hepatic dysfunction or severe renal dysfunction Patients with autoimmune diseases including systemic lupus erythematosus and rheumatoid arthritis
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Development & validation of a multivariable prognostic risk score for predicting composite MACE in patients with acute myocardial infarctionTimepoint: Baseline and intermediate follow-up 6 months and 12 months | — |
Secondary
| Measure | Time frame |
|---|---|
| Derivation of a simplified bedside risk score. Prognostic risk prediction model performance in young AMI. Incidence of MACE at baseline during follow-up using PSQI in patients with acute myocardial infarctionTimepoint: Baseline and intermediate follow-up 6 month and 12 months | — |
Countries
India
Contacts
Public ContactDr Tom Devasia
Kasturba Medical College , Manipal
Outcome results
None listed